Author

Su-Wen Lin

Observed names: Su-wen Lin, Suwen Lin

Institution: Hong Kong University of Science and Technology

Observed institution: Hong Kong University of Science and Technology

ORCID: 0000-0001-9769-3269

Observed ORCID: 0000-0001-9769-3269

OpenAlex ID: A5058408932

Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)

2023 · Guang Lu, Shikai Jin, et al. · Clinical Epigenetics · 38

Discovery of a novel, liver-targeted thyroid hormone receptor-β agonist, CS271011, in the treatment of lipid metabolism disorders

2023 · Suwen Lin, Shengjian Huang, et al. · Frontiers in Endocrinology · 14

Spatial Transcriptomics Analysis Reveals that CCL17 and CCL22 are Robust Indicators of a Suppressive Immune Environment in Angioimmunoblastic T Cell Lymphoma (AITL)

2022 · Jun Du, Chen Qiu, et al. · Frontiers in Bioscience-Landmark · 13

Efficacy and Treatment-Related Adverse Events of Romidepsin in PTCL Clinical Studies: A Systematic Review and Meta-Analysis

2021 · Jun Du, Xinle Han, et al. · Frontiers in Medicine · 10

CXCL1 Clone Evolution Induced by the HDAC Inhibitor Belinostat Might Be a Favorable Prognostic Indicator in Triple‐Negative Breast Cancer

2021 · Xin-le Han, Jun Du, et al. · BioMed Research International · 9

Improving Reporter Gene Assay Methodology for Evaluating the Ability of Compounds to Restore P53 Activity

2022 · Xinle Han, Jun Du, et al. · International Journal of Molecular Sciences · 3

Works count: 6

Citation count: 86

H-index: 5

I10-index: 4